Cargando…

P700: THE MECHANISM OF SETD2 IN MESENCHYMAL STEM CELLS REGULATED UBA5 IN MDS ERYTHROID DIFFERENTIATION

Detalles Bibliográficos
Autores principales:	Wang, Roujia, Chang, Chunkang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429224/ http://dx.doi.org/10.1097/01.HS9.0000969704.04925.cb

Ejemplares similares

The Ufm1-activating enzyme Uba5 is indispensable for erythroid differentiation in mice
por: Tatsumi, Kanako, et al.
Publicado: (2011)

P736: ANALYSIS OF RESPONSE RATES AND OUTCOMES IN ERYTHROID-PREDOMINANT MYELODYSPLASTIC SYNDROMES (MDS) TREATED WITH VENETOCLAX-BASED REGIMENS
por: Bazinet, Alexandre, et al.
Publicado: (2023)

Downregulation of MMP1 in MDS-derived mesenchymal stromal cells reduces the capacity to restrict MDS cell proliferation
por: Zhao, Sida, et al.
Publicado: (2017)

Overexpression of UBA5 in Cells Mimics the Phenotype of Cells Lacking UBA5
por: Kumari, Sujata, et al.
Publicado: (2022)

Setd1a and NURF mediate chromatin dynamics and gene regulation during erythroid lineage commitment and differentiation
por: Li, Ying, et al.
Publicado: (2016)

S100a9 deficiency accelerates MDS-associated tumor escape via PD-1/PD-L1 overexpression: S100a9 deficiency accelerates tumor escape
por: Wang, Roujia, et al.
Publicado: (2023)

P703: THE AIPSS-MDS MACHINE LEARNING MODEL PREDICTS OVERALL SURVIVAL AND LEUKEMIC TRANSFORMATION IN CMML: AN ANALYSIS OF THE SPANISH REGISTRY OF MDS
por: Mosquera-Orgueira, Adrian, et al.
Publicado: (2023)

P993: SETD2 IS A BONA FIDE TUMOR SUPPRESSOR IN SYSTEMIC MASTOCYTOSIS
por: Mancini, M., et al.
Publicado: (2022)

The histone methyltransferase Setd8 alters the chromatin landscape and regulates the expression of key transcription factors during erythroid differentiation
por: Myers, Jacquelyn A., et al.
Publicado: (2020)

P778: A CARTOGRAPHY OF UBA1 GENE TESTING, EPIDEMIOLOGY AND CLINICAL-GENOMIC CHARACTERISTICS: THE VEXAS ITALIAN EXPERIENCE
por: Gurnari, Carmelo, et al.
Publicado: (2023)

P1404: HDAC6 REGULATES HUMAN ERYTHROID DIFFERENTIATION THROUGH MODULATION OF JAK2 SIGNALING
por: Vong, P., et al.
Publicado: (2022)

A germline ERBB3 variant is a candidate for predisposition to erythroid MDS/erythroleukemia
por: Braunstein, Evan M., et al.
Publicado: (2016)

P1337: SURVIVAL EFFICACY OF MDS/AML PATIENTS WITH TP53 GENE ALTERATION RECEIVED ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Feng, D., et al.
Publicado: (2022)

SETD7 Regulates the Differentiation of Human Embryonic Stem Cells
por: Castaño, Julio, et al.
Publicado: (2016)

P705: AZACYTIDINE THERAPY REVERTS MDS-ASSOCIATED CHANGES IN MSC-DERIVED EXTRACELLULAR MATRIX
por: Bains, Amanpreet, et al.
Publicado: (2023)

Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS
por: List, A F, et al.
Publicado: (2014)

P1475: MUTATIONS IN THE GAP DOMAIN OF RACGAP1 CAUSE DEVELOPMENTAL AND ERYTHROID DEFECTS IN ZEBRAFISH
por: Romero-Cortadellas, Lídia, et al.
Publicado: (2023)

P702: APPLICATION OF NEXT GENERATION SEQUENCING (NGS) FOR MINIMAL RESIDUAL DISEASE (MRD) AND CHIMERISM MONITORING IN MYELODYSPLASTIC SYNDROME (MDS) AFTER ALLOGENIC STEM CELL TRANSPLANTATION (ASCT)
por: Zamanillo, Irene, et al.
Publicado: (2023)

P1290: UPFRONT ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION CAN PROVIDE SURVIVAL BENEFIT VERSUS HYPOMETHYLATING AGENT IN MYELODYSPLASTIC SYNDROME WITH INCREASED BLASTS I (MDS-IBI)
por: Runzhi, MA, et al.
Publicado: (2023)

Erratum: Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS
por: List, A F, et al.
Publicado: (2015)

P1358: MINING THE GENOME FOR ERYTHROID SPECIFIC ENHANCERS TO OPTIMIZE GENE THERAPY VECTORS FOR BETA-HEMOGLOBINOPATHIES
por: Paschoudi, Kiriaki, et al.
Publicado: (2023)

UBA80 and UBA52 fine-tune RNF168-dependent histone ubiquitination and DNA repair
por: Lee, Seong-Ok, et al.
Publicado: (2023)

P1405: ARGININE-DEPENDENT REGULATION OF THE EUKARYOTIC TRANSLATION INITIATION FACTOR (EIF)5A CONTROLS HUMAN HEMATOPOIETIC PROGENITOR FATE TO THE ERYTHROID LINEAGE
por: Gonzalez-Menendez, P., et al.
Publicado: (2022)

p38 MAPK in MDS
por: Gañán‐Gómez, Irene, et al.
Publicado: (2015)

Splicing factor SF3B1(K700E) mutant dysregulates erythroid differentiation via aberrant alternative splicing of transcription factor TAL1
por: Jin, Shuiling, et al.
Publicado: (2017)

PB2006: MOLECULAR CLINICAL CHARACTERISTICS AND PROGNOSIS OF MDS PATIENTS WITH RUNX1 MUTATION
por: Huang, Nanfang, et al.
Publicado: (2023)

P790: THE EXPRESSION LEVEL OF WT1 MRNA IN PATIENTS WITH IDIOPATHIC CYTOPENIA OF UNDETERMINED SIGNIFICANCE (ICUS) PROGRESSING TO MYELODYSPLASTIC SYNDROME (MDS)
por: Ye, X., et al.
Publicado: (2022)

P710: MONOCYTES MEDIATE NK CELL FUNCTION EXHAUSTION IN MDS PATIENTS VIA CD200/CD200R PATHWAY
por: Guo, Yixuan, et al.
Publicado: (2023)

P731: SURVIVAL IN LOWER-RISK MDS PATIENTS FROM EUMDS REGISTRY BY TWO TRANSPLANT SELECTION CRITERIA - IMPLICATIONS FOR TRANSPLANT DECISION
por: Savic, Aleksandar, et al.
Publicado: (2023)

Involvement in Fertilization and Expression of Gamete Ubiquitin-Activating Enzymes UBA1 and UBA6 in the Ascidian Halocynthia roretzi
por: Sawada, Hitoshi, et al.
Publicado: (2023)

A Method to Identify p62's UBA Domain Interacting Proteins
por: Pridgeon, Julia W., et al.
Publicado: (2003)

Oxidation of P700 Ensures Robust Photosynthesis
por: Shimakawa, Ginga, et al.
Publicado: (2018)

Shared and Distinct Mechanisms of UBA1 Inactivation Across Different Diseases
por: Collins, Jason C., et al.
Publicado: (2023)

700 solved problems in vector mechanics for engineers
por: Shelley, Joseph F.
Publicado: (1991)

Differentiation of human induced pluripotent stem cells into erythroid cells
por: Ebrahimi, Mohsen, et al.
Publicado: (2020)

P706: RESISTANCE TO HYPOMETHYLATING AGENTS (HMA) IN HIGH-RISKMYELODYSPLASTIC SYNDROME (HR-MDS): THE ROLE OF THE ADENOSINEDEAMINASE ACTING ON RNA 1 (ADAR1) ENZYME
por: Dimitriou, Despoina, et al.
Publicado: (2023)

P713: EXPLORING CLONAL COMPETITION THROUGH 12-YEAR FOLLOW-UP OF AN MDS-RS PATIENT WITH DUAL SF3B1 MUTATIONS
por: Moura, Pedro, et al.
Publicado: (2023)

P1458: MITAPIVAT AMELIORATES IN VITRO HUMAN Β THALASSEMIC ERYTHROID MATURATION INDEX AND MODULATES THE EXPRESSION OF THE CYTOPROTECTOR PEROXIREDOXIN-2.
por: Matte’, Alessandro, et al.
Publicado: (2023)

High-SETD8 inactivates p53 in neuroblastoma
por: Veschi, Veronica, et al.
Publicado: (2017)

UBA1: At the Crossroads of Ubiquitin Homeostasis and Neurodegeneration
por: Groen, Ewout J.N., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8ioflgtqqm1smllej1abdpsbv2